In the Past 30 Days...
PER WEEK
PER POST
PER POST
In the last 30 days, the average company in this landscape has grown their audience by 0.1%. Abbott grew faster than everyone else, with 0.8% growth! On average, each post in this landscape earns more than 78.9 engagements. Abbott is topping the charts with more than 348.1 engagements per post on their 26 posts in the last 30 days.
320 Likes • 5 Comments
Our U.S. #C2C4C participants rode nearly 3,000 miles across the U.S. through extreme conditions and raised more than $830,000 for cancer research. Swipe to see emotional moments from the finish line and visit the link in bio to support their fundraising efforts for theVFoundation through October 18.
221 Likes • 14 Comments
Donating blood for the free snacks? We have no idea what you’re talking about. Sign up to help your school win “The #WeGiveBlood Drive,” a bigten conference-wide blood donation competition at BigTen.Org/Abbott
162 Likes • 0 Comments
We are delighted to announce that we will be hosting an Instagram Live on Wednesday 30th October 2024 18.00 CET - 19.00 CET. Joining us will be Julie and Grace, two mothers who share something in common, multiple sclerosis (MS). We will delve into the world of motherhood, from pregnancy to toddlers as well as all the …
133 Likes • 0 Comments
We united with patients from around the world to celebrate our 10th #GlobalPatientWeek and heard stories of hope, perseverance and courage. Swipe to see memorable moments from our annual patient celebration that inspire us to put patients at the center of everything we do. Visit the link in bio to see patient stories and learn more.
110 Likes • 2 Comments
This is Nadya. A traveller, painter and winner of the Neva Krasa International Beauty and Talent Contest. She does not let spinal muscular atrophy define who she is. Her paintings are often inspired by her emotions, the environment, and influential artists like #VincentVanGogh – describing her style as “gentle and light.” Swipe to see more of her …
95 Reactions • 0 Comments • 2 Shares
After riding nearly 3,000 miles across the U.S. through extreme conditions and raising more than $830,000 for cancer research, it was an incredible finish for our #C2C4C riders this week! See the emotional moments after their final ride and learn how you can support their fundraising efforts for The V Foundation for Cancer Research through …
59 Reactions • 30 Comments • 3 Shares
This American Pharmacist Month, we want to thank all our dedicated pharmacists who go above and beyond, providing high-quality pharmacy care when and where their patients need it.
76 Reactions • 0 Comments • 4 Shares
The U.S. FDA has now approved our immunotherapy-based treatment as a perioperative regimen for certain patients with resectable non-small cell lung cancer. https://bit.ly/3N9kt3x
52 Reactions • 0 Comments • 1 Shares
Our colleagues in Japan are undertaking their epic #C2C4C ride for cancer research, cycling nearly 1,800 kilometers from Tokyo Bay to Otemachi, Tokyo to honor patients with cancer, including their loved ones. Learn how you can support their journey to raise funds for キャンサーネットジャパン（CancerNetJapan） : https://bit.ly/3TZcU3g
31 Reactions • 5 Comments • 4 Shares
The coaches talk a B1G game, but which school is going to take home “The #WeGiveBlood Drive” win? We’re hosting a Big Ten Conference-wide blood donation competition and all alumni, fans and students can donate blood and help their school win $1MM to advance student and community health. Sign up: https://abbo.tt/4emmzco
28 Likes • 10 Retweets
#GileadNews: At #HIVR4P2024 we announced data from our second Phase 3 clinical trial of our investigational medication for #HIV prevention. Results highlight the potential for the medication, if approved, among cisgender men and gender-diverse individuals. gilead.inc/47Xsty4 pic.x.com/Wewrz3psb0
25 Likes • 7 Retweets
Oregon fans! 📣💚💛 Now’s your chance to climb the ranks from 9th to 🏆 in "The #WeGiveBlood Drive." On-campus blood drive: 📅 Wednesday, October 9 ⏰ 8 AM – 2:30 PM 📍Basement Court of Gerlinger Annex Register Here: abbo.tt/3Bz6jWN pic.x.com/5XEOgN980P
Congrats to the @NobelPrize 2024 laureates Victor Ambros & Gary Ruvkun! Their discovery of #microRNA revolutionised gene regulation and opened new avenues for medical research, impacting diseases like #cancer, #diabetes, and #autoimmunity. 👏 #NobelPrize x.com/NobelPrize/sta…
19 Likes • 7 Retweets
19 Likes • 4 Retweets
#GileadNews: We’re donating our antiviral therapy to Rwanda for emergency use. The current #Marburg outbreak there is one of the largest in history, and this donation continues our legacy of responding to devastating health crises around the world. gilead.inc/3BvPLio pic.x.com/h6dxa6vtv0
17 Likes • 3 Retweets
#NEWS: Today we have officially completed our acquisition of V-Wave, a privately-held company developing innovative treatment options for patients with heart failure. Click here for more information: social.jnj.com/3NkF7xM pic.x.com/MmpakJoLBC
The Social Media Benchmark Report
Ready to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.